These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 271353

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A, Verdeaux J, Letalle A.
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
    McCall RB, Aghajanian GK.
    Life Sci; 1980 Apr 07; 26(14):1149-56. PubMed ID: 7392793
    [No Abstract] [Full Text] [Related]

  • 27. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI.
    Science; 1976 May 21; 192(4241):801-3. PubMed ID: 1063447
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of hallucinogens on blind monkeys.
    Siegel RK, Brewster JM, Johnson CA, Jarvik ME.
    Int Pharmacopsychiatry; 1976 May 21; 11(3):150-6. PubMed ID: 11193
    [Abstract] [Full Text] [Related]

  • 30. Effects of drugs on perception in man.
    Malitz S, Kanzler M.
    Res Publ Assoc Res Nerv Ment Dis; 1970 May 21; 48():35-53. PubMed ID: 4917959
    [No Abstract] [Full Text] [Related]

  • 31. The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.
    Haefely W.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 May 21; 281(2):145-65. PubMed ID: 4361056
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD, Jenden DJ, Mickey MR, Yale C.
    Pharmacol Biochem Behav; 1980 Jan 21; 12(1):99-105. PubMed ID: 6102770
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW.
    Adv Drug Res; 1973 Jan 21; 7():165-206. PubMed ID: 4613150
    [No Abstract] [Full Text] [Related]

  • 38. Management of hallucinogen abuse.
    Haddad LM.
    Am Fam Physician; 1976 Jul 21; 14(1):82-7. PubMed ID: 1065215
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.
    Dyer DC, Gant DW.
    J Pharmacol Exp Ther; 1973 Feb 21; 184(2):366-75. PubMed ID: 4347258
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.